Journal of Clinical Lipidology Sees Another Increase in Impact Factor

The 2015 Impact Factors were recently released and the Journal of Clinical Lipidology (JCL) saw yet another significant increase — from 3.904 (2014) to 4.906 (2015). The Journal is now ranked 23rd out of 253 journals in its category (pharmacology and pharmacy). The Thomson-Reuters Impact Factor represents the ratio of articles quoted in other scientific publications compared to the total qualifying articles during the years 2013 and 2014. 

W. Virgil Brown, MD, FNLA, editor-in-chief of the JCL, said that the increase is comparable to other journals that he considers pace-setters in our field. "This reflects the growth in number of high quality submissions reviewed and accepted during these years," says Dr. Brown. "Our receiving manuscripts with impactful information depends greatly on the thoughtful reviews provided by our excellent Editorial Board."  

He also credits the increase of the Impact Factor to the growth of outstanding manuscripts being submitted from around the world. "The Journal is able to publish about 40 percent of submitted manuscripts," he says. "The most important measure of success is evidence that these manuscripts are being read. The number of downloads of full length articles during the first half of 2016 is15,000 per month or 180,000 per year. We are being read throughout the world and most downloads are in institutions of great reputation for scientific and academic excellence." 

Dr. Brown wants to thank the Editorial Board and the staff at the National Lipid Association and at Elsevier for their strong team effort that is he says is making this possible.